Karo Pharma AB | |
Stock Exchange | OTC Publication Venue |
EPS |
SEK4.62 |
Market Cap |
SEK6.25 B |
Shares Outstanding |
164.33 M |
Public Float |
48.16 M |
Address |
Nybrokajen 7 Stockholm AB 111 48 Sweden |
Employees | - |
Website | http://www.karopharma.se |
Updated | 07/08/2019 |
Karo Pharma AB is a healthcare company, which engages in the research, development, and distribution of innovative drugs for key medical needs. It focuses on the project portfolio consists of RORgamma, Multiple Sclerosis and Cancer, and T268A Common Cold Spray. The company was founded in 1987 and is headquartered in Stockholm, Sweden. |